跳至主要内容
临床试验/NL-OMON49810
NL-OMON49810招募中4 期

Surgical excision versus photodynamic therapy and topical 5-fluorouracil in treatment of Bowen*s disease: a multicenter randomized controlled trial - BOWTIE

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Adults >= 18 years
  • -Histologically proven primary Bowen*s disease
  • -Lesions >= 4mm and <= 40mm in diameter
  • -Fitzpatrick skin type I-IV
  • -Female in child bearing potential should be using contraceptive measures,
  • during and till 3 months post-treatment

排除标准

  • -Bowen's Disease located at ears, periocular, nail , nail unit or periungual
  • tissue, nose (limited light exposure for PDT), genital and mucous membranes
  • (different entities)
  • -High clinical suspicion of invasive SCC
  • -Interfering treatment of other (N)MSC in target area
  • -Breastfeeding
  • -Pregnancy
  • -Allergy to study drugs
  • -Not able to self-apply cream on lesions located on the back or other difficult
  • to reach locations
  • -Genetic skin cancer disorders
  • -Not understanding Dutch language
  • -Porphyria
  • -Not able to give informed consent
  • -Immuno-compromised status
  • -Use of systemic retinoid in the past 3 months
  • -Use of immunosuppressant drugs in the past 3 months and / or at time of
  • treatment (such as oral glucocorticoids, cytostatic, antibodies, drug acting on
  • immunophilins, in-terferon, opioids, TNF binding proteins, MMF, biologic
  • agents). inhalation corticoster-oids / nasal corticosteroids are permitted.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验